ClinicalTrials.govpublic full text
Withdrawal of Prostacyclin Pathway Therapy in Patients With Pulmonary Arterial Hypertension Receiving Sotatercept (WATERLOO)
pulmonary arterial hypertension, prostacyclin, sotatercept, open label, non-inferiority, weatherald, canadian vigour centre, cvc, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1030256
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.